Much later, in the 19th Century, swimming pools emerged in Britain and the US. But along with them came the challenge of ...

A dreaded fungus known to inhabit tombs has been reconstituted as a treatment for leukemia and is performing as effectively ...

Dual hepatitis C virus (HCV)/hepatitis B virus (HBV) infection is not uncommon in HCV or HBV endemic areas and among subjects at risk of parenteral transmission. In patients dually infected with ...

PRESS RELEASE Memo Therapeutics AG to Present Interim Phase II Results of Potravitug for the Treatment of BKV Infection in Kidney Transplant Recipients in a Late Breaking Oral Presentation at the ...

We aren't quite clear of peak norovirus season just yet, and if you come down with the debilitating virus, the symptoms could linger in your system for some time. Here's what you need to know if ...

With no currently approved vaccine, norovirus causes millions of infections globally resulting in billions of dollars of economic burden,” said Steven Lo, Chief Executive Officer of Vaxart.

Vaxart, Inc., a biotechnology company focused on oral recombinant pill vaccines, announced it will release topline data from its Phase I trial on norovirus before the market opens on June 11, 2025.